20.07.2011 • News

Johnson & Johnson Q2 Profit Down

Johnson & Johnson reported that its second-quarter net earnings were $2.776 billion or $1 per share, down from $3.449 billion or $1.23 per share in the same quarter last year. Adjusted net earnings rose to $3.548 billion or $1.28 per share, from $3.382 billion or $1.21 per share in the year ago quarter. Analysts polled by Thomson Reuters expected the company to report earnings of $1.23 per share for the quarter. Analysts' estimates typically exclude special items.

Sales for the quarter rose to $16.60 billion from $15.33 billion in the prior year quarter. Eleven analysts had consensus revenue estimate of $16.22 billion for the quarter.

The company maintained its earnings guidance for full-year 2011 of $4.90-$5 per share. Analysts expect the company to report earnings of $4.95 per share for fiscal 2011.

 

 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.